Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02960594
Title hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Inovio Pharmaceuticals
Indications

colorectal cancer

stomach cancer

breast carcinoma

lung carcinoma

ovarian carcinoma

esophageal cancer

head and neck squamous cell carcinoma

hepatocellular carcinoma

pancreatic carcinoma

Therapies

INO-1400 + INO-9012

INO-1400

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
University of Pittsburgh Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field